Endocrine Flashcards
What is T1 diabetes
A progressive destruction of islet B cells
Onset usually <40 years
Autoantibodies may be detected
Tendency to ketosis
Treated with exogenous insulin combined with a healthy diet and exercise
What are the different types of insulin preparations
Short acting:
- soluble
- analogues (rapid-acting: lispro, aspart)
Intermediate acting:
- isophane (complexed with protamine)
Long acting:
- insulin zinc suspension
- analogues (glargine, detemir)
Biphasic:
- mix of short and intermediate acting insulins
What is DAFNE
Dose adjustment for normal eating
- adjusting insulin regimens to suit the individual lifestyle
What can increase insulin requirements
Stress
Infection
Puberty (GH)
Accidental or surgical trauma
Pregnancy post 1st trimester
Why does insulin injection site need to be rotated
To limit Lipodystrophy
What is T2 diabetes
Relative insulin deficiency (impaired B cell function) and / or insulin resistance
- impaired insulin signalling pathways
- nutrient oversupply, cellular stress and inflammation
How is T2DM managed
Diet and lifestyle changes
Agree on a glycaemic target (HbA1c)
Cardiovascular risk management
Management of CKD
Pharmacotherapy
How should people with T2DM adjust their lifestyle
Exercise
Smoking cessation
When should metformin be cautioned
Patients with renal impairment
What should be given first line if metformin is inappropriate in T2DM
DPP-4 inhibitor
Pioglitazone
Sylphonlyurea
SGLT2 inhibitor
When is an SGLT2 inhibitor given with metformin
If the CVD/ CHF/ QRISK2 is >10%
When is insulin given in T2DM
After triple therapy has not been effective
What is metformin
MoA not clear, described as an insulin sensitiser
May activate AMP kinase
- reduces hepatic glucose production, reduces lipid stores, increases liver sensitivity to insulin
- increases peripheral glucose uptake and utilisation
What are sulphonylureas
Inhibit islet B cell ATP sensitive potassium channels - increase insulin secretion
Cause weight gain as a side effect, hypoglycaemia especially with long acting
What is pioglitazone
Activates nuclear peroxisome proliferator activated receptors
An insulin sensitiser - enhances glucose utilisation in tissues and reduces insulin resistance
Reduces hepatic glucose output
Increases glucose uptake and utilisation in skeletal muscle
Increases fatty acid uptake into adipose cells
Adverse effects of pioglitazone
Liver toxicity (monitor)
Avoid in heart failure
Increased risk of bladder cancer and bone fractures
What do incretins (GLP-1) do
Stimulate glucose induced insulin release
And inhibit glucagon release
What are some benefits of incretin based therapies
Reduce gastric emptying
Promote satiety
Reduce hepatic glucose production
What do SGLT2 inhibitors do
Inhibit renal glucose reabsorption and increase urinary glucose excretion which reduces blood glucose
Cardiovascular and renal benefits
Side effects of SGLT2 inhibitors (flozins)
Genitourinary infections
Increased urination, thirst
Hypovolaemia, hypotension
DKA
What are complications of diabetes treatment
Hypoglycaemia (insulin SUs)
Diabetic ketoacidosis: lack of insulin; SGLT2 inhibitors
Hyperosmolar hyperglycaemic state (HHS, T2DM)
What are Microvascular complications
Damage of the small vessels
1. Retinopathy (eye)
2. Nephropathy (kidney disease)
3. Neuropathy (nerve damage)